Circular RNA: A novel potential biomarker for skin diseases. (August 2020)

• Record Type: Journal Article
• Authors: Wu, Xiaoting; Xiao, Yanwei; Ma, Jingxin; Wang, Aoxue
• Is Part Of: Pharmacological research. Volume 158(2020)
• Publication Date: 2020-08
• Subjects: CircRNA -- Skin diseases -- Biomarker -- N6-methyladenosine (m6A) modification -- Melanoma -- Wound healing; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2020.104841
• Languages: English
• ISSNs: 1043-6618

Abstract

Highlights: Circular RNA (circRNA) with a covalent closed continuous loop, the 3'and 5' ends of which are normally joined together, can function as regulators to participate in different diseases. Accumulating investigations have found that many circRNAs are abnormally expressed in skin disorders such as malignant melanoma, psoriasis and abnormal wound healing. Because circRNAs can participate in the occurrence and development of skin diseases through a variety of molecular mechanisms, and have special structural and functional properties (stability, specificity and sensitivity), they are promising in serving a biomarker for diagnosis, prognosis, and therapy of skin diseases. The RNA modification and secondary structure of circRNA need further exploration, and the circRNA abundance in plasma or other body fluids will need to be detected in the future to determine their suitability as non-invasive biomarkers for the diagnosis or prediction of skin diseases. And the safety and reliability of circRNAs as biomarkers or therapeutic targets in skin diseases need more verification. Moreover, the standardization of bioinformatics tools and the establishment of skin-related circRNA databases are crucial. Graphical abstract: Abstract: Circular RNA (circRNA) has been classified as noncoding RNA with a covalent closed continuous loop, the 3′and 5′ ends of which are normally joined together to increase its own stability. More recently, circRNA has been shown to encode proteins and may be involved in the regulation of gene transcription. This provides more evidence for the involvement of circRNA in disease progression. Accumulating investigations have found that the expression of many circRNAs is abnormal in plenty of skin diseases such as malignant melanoma, psoriasis, and abnormal wound healing. Herein, in addition to the summary of recent studies on the nuclear export, N 6 -methyladenosine (m 6 A) modification, degradation, and other biogenesis and properties of circRNA, we highlight the importance of circRNAin skin diseases. Although their exact roles and mechanisms in most skin disease remain preliminary, circRNAs have potential applications as diagnostic biomarkers and novel therapeutic targets for skin diseases due to its structural and functional properties (stability, specificity and sensitivity), which is worthy of deeper exploration and greater research efforts.